Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL699721 | 0.84 | SLC6A2 (0.36) | ALDH1A1TSHRLMNA | |
| SCHEMBL4336944 | 0.76 | ALDH1A1 (0.46) | ALDH1A1TSHRPOLBCA1CA2 | |
| SCHEMBL700377 | 0.74 | MAPT (0.33) | — | |
| SCHEMBL699590 | 0.73 | ALDH1A1 (0.39) | ALDH1A1TSHRPOLB | |
| Trimethylammonium SCHEMBL8979578 | 0.72 | ALDH1A1 (0.50) | ALDH1A1TSHRPOLBCA1CA2 | |
| SCHEMBL701320 | 0.70 | ALDH1A1 (0.33) | ALDH1A1LMNA | |
| SCHEMBL700276 | 0.69 | ALDH1A1 (0.30) | ALDH1A1TSHR | |
| SCHEMBL8979454 | 0.67 | ALDH1A1 (0.43) | ALDH1A1TSHR | |
| SCHEMBL26019045 | 0.67 | ALDH1A1 (0.65) | ALDH1A1TSHR | |
| SCHEMBL701137 | 0.65 | MAPK1 (0.32) | ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1688424-B1 | PHOSPHONIUM BORATE COMPOUND AND METHOD OF USING THE SAME | HOKKO CHEM IND CO (JP) | 2016-01-13 | — | — | EP | disclosed |
| US-8124809-B2 | Process for producing phosphonium borate compound, novel phosphonium borate compound, and method of using the same | HOKKO CHEMICAL INDUSTRY CO., LTD. (JP) | 2012-02-28 | — | — | US | disclosed |
| US-20110237799-A1 | Process for Producing Phosphonium Borate Compound, Novel Phosphonium Borate Compound, and Method of Using the Same | HOKKO CHEMICAL INDUSTRY CO., LTD. (JP) | 2011-09-29 | — | — | US | disclosed |
| US-20110166389-A1 | Process for Producing Phosphonium Borate Compound, Novel Phosphonium Borate Compound, and Method of Using the Same | HOKKO CHEMICAL INDUSTRY CO., LTD. (JP) | 2011-07-07 | — | — | US | disclosed |
| US-7728176-B2 | Process for producing phosphonium borate compound, novel phosphonium borate compound, and method of using the same | HOKKO CHEMICAL INDUSTRY CO., LTD. (JP) | 2010-06-01 | — | — | US | disclosed |
| US-20070098616-A1 | Process for producing phosponium borate compound, novel phosphonium borate compound, and method of using the same | HOKKO CHEMICAL INDUSTRY CO., LTD. (JP) | 2007-05-03 | — | — | US | disclosed |
| EP-1688424-A1 | PROCESS FOR PRODUCING PHOSPHONIUM BORATE COMPOUND, NOVEL PHOSPHONIUM BORATE COMPOUND, AND METHOD OF USING THE SAME | HOKKO CHEMICAL INDUSTRY CO. LTD. (JP) | 2006-08-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110166389-A1 | Process for Producing Phosphonium Borate Compound, Novel Phosphonium Borate Compound, and Method of Using the Same | CA4, EPB41, MAPK4 | ALDH1A1 4654/4885TSHR 2082/4885POLB 1500/4885 |
| US-20110237799-A1 | Process for Producing Phosphonium Borate Compound, Novel Phosphonium Borate Compound, and Method of Using the Same | EPB41, CA4, RBBP4 | ALDH1A1 4626/4885TSHR 1831/4885POLB 1257/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.